For the Inventor, By the Inventor

Enter assignee name

New Brunswick, NJ, United States of America

Senesco Technologies, Inc.

USPTO Granted Patents = 16

% Expired Patents = 87.5

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 18

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

John E Thompson (16 out of 32 patents)

Catherine Taylor (10 out of 11 patents)

Tzann-Wei Wang (8 out of 22 patents)

4. Dominic O Cliche (6 out of 6 patents)

5. John C Carlson (4 out of 5 patents)

6. Richard Narayansingh (4 out of 4 patents)

7. Larry Petrov (4 out of 4 patents)

8. Charles A Dinarello (3 out of 45 patents)

9. Bruce C Galton (3 out of 3 patents)

10. Adrienne Boone (3 out of 3 patents)

11. Dongen Lily Lu (3 out of 15 patents)

12. Leonid Reznikov (2 out of 3 patents)

13. Marianne Hopkins (2 out of 2 patents)

14. Richard S Dondero (2 out of 4 patents)

15. Elizabeth Heikkila (2 out of 3 patents)

16 patents: Sort by Forward Citations

1. 8754057 - Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics (2014-06-17),

2. 8703929 - Compositions comprising siRNA and plasmids (2014-04-22),

3. 8563285 - Isoforms of eIF-5A: senescence-induced eIF5A; wounding-induced eIF-5A; growth eIF-5A; and DHS (2013-10-22),

4. 8445638 - Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells (2013-05-21),

5. 8242256 - siRNA useful to supress expression of EIF-5A1 (2012-08-14),

6. 8232455 - Polynucleotides encoding canola DHS and antisense polynucleotides thereof (2012-07-31),

7. 8193158 - Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis (2012-06-05),

8. 7968523 - Method for inducing apoptosis using apoptosis-specific EIF5-A (2011-06-28),

9. 7872112 - Expression vector encoding apoptosis-specific eIF-5A (2011-01-18),

10. 7663028 - Method of increasing seed yield and growth eIF-5A (2010-02-16),

11. 7662796 - Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 (2010-02-16),

12. 7588888 - DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants (2009-09-15),

13. 7358418 - Isoforms of eIF-5A: senescence-induced eLF5A; wounding-induced eIF-4A; growth eIF-5A; and DHS (2008-04-15),

14. 7217517 - Nucleic acids, polypeptides, and methods for modulating apoptosis (2007-05-15),

15. 7166467 - Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis (2007-01-23),

Senesco Technologies, Inc. is a biotechnology company focused on developing therapies for cancer treatment. Their proprietary technology, known as SNS01-T, is designed to selectively kill cancer cells while sparing normal cells, providing a potential targeted treatment option. With a mission to improve patient outcomes and quality of life, Senesco Technologies is committed to advancing innovative therapies in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

16 Patents

#9 in New Brunswick, NJ

#755 in New Jersey

#19,874 in US

#37,717 in the World

New Brunswick, NJ, United States of America

Senesco Technologies, Inc.

Forward Citations = 18

25 inventors:

John E Thompson (16 out of 32 patents)

Catherine Taylor (10 out of 11 patents)

Tzann-Wei Wang (8 out of 22 patents)

4. Dominic O Cliche (6 out of 6 patents)

5. John C Carlson (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…